Small cell lung cancer is known for its high malignancy and rapid progression. Many patients feel that there is little hope for treatment upon hearing this diagnosis.
But in fact, small cell lung cancer is not a monolithic disease - if it is in the limited stage, with standardized treatment, there is still a chance to significantly prolong survival.
In this issue, we have invited Professor Yang Nong, a specially-appointed expert from Hainan Cancer Hospital/Affiliated Cancer Hospital of Hainan Medical University, to provide a detailed analysis of issues that patients are concerned about. By combining this with the guidelines for lung cancer diagnosis and treatment, we aim to help everyone cope with these issues with ease.
Is there a high chance for the treatment of limited-stage small cell lung cancer?
Professor Yang Nong: Don't give up on small cell lung cancer. There are standardized radical treatment plans for limited-stage small cell lung cancer, and the right treatment can significantly prolong survival.
Many people panic immediately when they are diagnosed with small cell lung cancer, but in fact, there is still a great chance for treatment in the limited stage.
Limited-stage refers to the condition where the tumor is confined to one side of the chest cavity without distant metastasis. By strictly adhering to clinical guidelines and standardized treatment, the prognosis can be significantly improved.
What is the standard treatment regimen for limited-stage small cell lung cancer?
Professor Yang Nong: Currently, there are two standard treatment options available in clinical practice.
The first approach: Concurrent chemoradiotherapy + immune consolidation
This is the most commonly used core protocol in clinical practice. Chemotherapy and radiotherapy are conducted simultaneously to synergistically eliminate cancer cells in the body.
After the completion of concurrent chemoradiotherapy, patients with good physical tolerance and no contraindications are recommended to undergo up to 2 years of immune consolidation therapy, which can effectively reduce the probability of tumor recurrence.
The second approach: radical surgery + adjuvant chemotherapy
It is only applicable to a very small number of extremely early-stage patients with small tumor lesions and no lymph node metastasis.
Before the pathological results are confirmed, if the doctor assesses that the tumor can be completely removed, a radical surgery will be performed, followed by four cycles of adjuvant chemotherapy.
However, small cell lung cancer is highly malignant and aggressive, and most patients have lymph node metastasis when diagnosed, making eligible patients for surgery very rare.
Small cell lung cancer is relatively malignant, but limited-stage disease does not equate to a terminal illness. After diagnosis, it is important to seek treatment at a reputable medical institution as soon as possible, following standardized protocols. This can help maximize the chances of achieving longer survival and better quality of life.
Expert Introduction
Yang Nong
Chief Physician, Doctoral Supervisor
Hainan Cancer Hospital/Affiliated Cancer Hospital of Hainan Medical University
Long-term employed expert of Hainan Chengmei Hospital
He currently serves as Vice President of the Second People's Hospital of Hunan Province, leader of the oncology department, and head of the "Yang Nong Famous Doctor Clinic" / "Yang Nong Famous Doctor Expert Team Clinic". He is also the chief expert of the National Major Scientific and Technological Special Project, a member of the Lung Cancer Special Committee of the National Cancer Quality Control Center, the director of the Hunan Provincial Key Laboratory of Precision Diagnosis and Treatment of Lung Cancer, and the director of the Hunan Provincial Respiratory Oncology Clinical Medical Research Center.
He has been engaged in precision targeted therapy for lung and gastrointestinal cancers, as well as clinical practice, research, and teaching on difficult, recurrent, and drug-resistant cases for nearly 30 years.
He has been honored with titles such as the "Outstanding Model of National Famous Doctors" in the 6th edition, the "Annual Excellent Doctor" for eight consecutive years, and the "First Brain Doctor and Famous Doctor". He has authored national guidelines and has long been engaged in the popularization of tumor health knowledge.
Specialization
Precision treatment for lung cancer, diagnosis and treatment of difficult, recurrent, and drug-resistant cases, as well as brain metastasis; individualized precision treatment for brain metastases of lung cancer; early diagnosis of pulmonary nodules and lung cancer; personalized comprehensive diagnosis and treatment for pan-solid tumors; clinical trials of the latest immune/targeted therapy drugs.
With nearly 30 years of experience in precision immunotherapy for lung cancer, he has led nearly 400 clinical trials of phase I-III anticancer drugs (including national Class 1 new drugs).
We have been engaged in comprehensive diagnosis and treatment for multiple cancer types, tailored to individual needs, and involving multiple disciplines for a long time.
Visit information
Clinic Hours
On the morning of October 11th
Visit location
Sixth Consultation Area of Hainan Cancer Hospital
appointment registration
Follow the official account of Hainan Cancer Hospital to "make an appointment and register"
health consultation
18976324546
Friendly Reminder
To facilitate the experts in understanding your condition as soon as possible, please bring along:
●ID card, medical insurance card, mobile phone
●Accompany immediate family members (with decision-making authority)
● Arrange the relevant examinations you have undergone in chronological order
● Paper medical records of previous visits
●Surgical case sections: wax blocks or 20-30 white sections
● Pathological diagnosis report
● Inpatient medical records and notes
● Recent relevant examinations
● The patient's current treatment plan
● The most urgent questions to consult
[Friendly reminder: This article is intended for health education purposes and serves as a general health reference only. It does not constitute medical advice. If you experience any discomfort, please seek in-person consultation and evaluation at a reputable medical institution.]